BioSpace News Archive

Faculty, programs will expand in neuroengineering, synthetic biology, physical biology

Amphion Innovations plc announces that the Company has agreed terms for re-structuring the loan payments under the Facility and the draw-down of an additional US $1.1 million (net after fees and expenses) under the loan facility as announced on 5 June 2014 (the “Facility”).

Company announces patented blood-based diagnostic test expanding to other autoimmune diseases as well as cancer

DeltaTrak® introduces the next generation FlashLink Mini PDF In-Transit Logger at PMA Fresh Summit, Booth 1562, October 19 - 20, 2018, at the Orange County Convention Center, Orlando Florida.

MDxHealth SA (Euronext Brussels: MDXH) (“MDxHealth” or the “Company”), announced that it received on October 12, 2018 the following notification of significant shareholdings in accordance with the Belgian Act of May 2, 2007 on the disclosure of important participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions (the “Belgian Transparency Act”).

DNAe was named ‘Best Diagnostic Medtech Company’ at the 2018 OBN Awards.

Locate Bio Limited today announces that it has changed its name from Locate Therapeutics Limited and received a new direct investment of £0.5 million from Mercia Technologies PLC (AIM: MERC) (“Mercia”).

Hitachi, Ltd. announced today that its heavy ion beam therapy system(1) has started treatment at Osaka Heavy Ion Therapy Center as of October 16. This marks the first operation of Hitachi’s first heavy ion therapy system.

DeltaTrak® will be highlighting its new FlashTrak PreCool Prime at PMA Fresh Summit, Booth 1562, on Oct. 19-20, 2018, at the Orange County Convention Center, Orlando, Florida.

Five oral and poster presentations highlight utility of OncoDNA’s comprehensive testing of cancer biomarkers and cancer treatment database